The other night we had a very provocative discussion about prostate cancer treatments. There are many treatments and, unfortunately, no clear answers as to which is the right one and when. Yes, there are strong recommendations to do this or that in a given situation, but is anyone in urologic oncology really sure what's best for cancer control and quality of life? No. And can you have total confidence in every study? No. Some are just plain self-serving for shaded" for practitioners of this approach or that.

That point was driven home by urologic oncologist Dr. Bruce Dalkin, a new professor at the University of Washington and expert at the Seattle Cancer Alliance. In this 70 minute webcast, he displays his passion for outcomes research and why he's been surveying patients before and after treatment for more than eight years. He feels, and we do too, that men deserve more evidence for treatments – not shaded by a doctor's bias, and a better understanding of how results vary by doctor.

Prostate cancer, like so many other medical areas now, has many new devices, radiation and surgical approaches, and drugs. There's even a strategy to have "active surveillance" and just monitor the situation. Which approach is right varies by who you ask and maybe whether a given doctor has access to a specific approach. When it comes to prostate cancer there is definitely a juncture between the business of medicine and the practice of medicine.

All of this is discussed frankly and openly on this webcast and I hope men will take time to listen – women too, if someone they know may be affected.

While which treatment is right, or having treatment at all isn't really clear at this time, what IS clear is that a man should get a second opinion and do his research. Also, in most cases there is not a reason to rush to get treatment because it is likely the cancer has been developing over an extended time. Taking a bit longer for a well thought-out plan that you choose with confidence is best.

We are delighted our programs can bring clarity when there is clarity to be had. We also believe it is our mission to delve into controversy when that lies before us too.

Trust me, our job is to help you be a truly empowered patient even if the answers are not always easy. In prostate cancer, that is certainly the case.

We welcome your comments any time.

Wishing you and your family the best of health and reminding you that knowledge can be the best medicine of all,

Andrew